Mortality in psoriatic arthritis patients, changes over time, and the impact of COVID-19: results from a multicenter Psoriatic Arthritis Registry (PsART-ID)
Background This study aimed to assess the mortality of PsA before and during the COVID-19 pandemic. Methods From the prospective, multicenter PsART-ID (Psoriatic Arthritis Registry-International Database), patients from Turkey were analyzed by linking the registry to the Turkish Cause of Death Regis...
Gespeichert in:
| Veröffentlicht in: | Clinical rheumatology 2023-02, Vol.42 (2), p.385-390 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 390 |
|---|---|
| container_issue | 2 |
| container_start_page | 385 |
| container_title | Clinical rheumatology |
| container_volume | 42 |
| creator | Erden, Abdulsamet Ayan, Gizem Kilic, Levent Solmaz, Dilek Bakirci, Sibel Kimyon, Gezmis Günal, Esen Kasapoglu Dogru, Atalay Bayindir, Ozun Dalkilic, Ediz Özisler, Cem Akar, Servet Cetin, Gözde Yildirim Tarhan, Emine Figen Küçüksahin, Orhan Omma, Ahmet Gonullu, Emel Yildiz, Fatih Ersozlu, Emine Duygu Cinar, Muhammed Tufan, Abdurrahman Pehlevan, Seval Esmen, Serpil Ergulu Yilmaz, Sema Duruoz, Tuncay Kasifoglu, Timucin Yazısız, Veli Aksu, Kenan Aydin, Sibel Zehra Kalyoncu, Umut |
| description | Background
This study aimed to assess the mortality of PsA before and during the COVID-19 pandemic.
Methods
From the prospective, multicenter PsART-ID (Psoriatic Arthritis Registry-International Database), patients from Turkey were analyzed by linking the registry to the Turkish Cause of Death Registry. The outcome of interest was death from any cause, pre-pandemic (since the onset of registry—March 2014–March 2020), and during the pandemic (March 2020–May 2021). The crude mortality rate and standardized mortality ratio (SMR) were determined.
Results
There were 1216 PsA patients with a follow-up of 7500 patient-years. Overall, 46 deaths (26 males) were observed. In the pre-pandemic period, SMR for PsA vs the general population was 0.95 (0.61–1.49), being higher in males [1.56 (0.92–2.63)] than females [0.62 (0.33–1.17)]. The crude mortality rate in PsA doubled during the pandemic (pre-pandemic crude mortality rate: 5.07 vs 10.76 during the pandemic) with a higher increase in females (2.9 vs 8.72) than males (9.07 vs 14.73).
Conclusion
The mortality in PsA was found similar to the general population in the pre-pandemic era. The mortality rates in PsA doubled during the pandemic. Whether PsA patients have more risk of mortality than the general population due to COVID-19 needs further studies.
Key Points
• Decrease in mortality in PsA might be expected with the more effective treatment options and better disease control.
• A crude mortality rate is comparable to the general population and not increased until the pandemic.
• Currently, there is a 2-fold increase in crude mortality rate possibly due to the COVID-19. |
| doi_str_mv | 10.1007/s10067-022-06492-6 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9838281</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2765775988</sourcerecordid><originalsourceid>FETCH-LOGICAL-c474t-6e71bf4da070f7eff050b2f8beb66ee6481a623925c5e90f4fb8dd79f727f4273</originalsourceid><addsrcrecordid>eNp9kc1uEzEUhS1ERUPhBVggS2yKVIP_xh6zQIpSKJGKWlWFreWZsRNXM-PBdirlXXhYHFLCz4KNrat77jn36gPgBcFvCMbybSqvkAhTirDgiiLxCMwIZxwpxdVjMMNSYsSIqo_B05TuMMa0VuQJOGZCMCmYmIHvn0PMpvd5C_0IpxSiN9m30MS8jj77BKdS2zGnM9iuzbiyCYZ7G2H2gz2DZuxgXlvoh8m0GQYHF1dfl-eIqHcw2rTpc4IuhgEaOJTCt8WpDF8fcuaHnBu78inHLTy9TvObW7Q8f_0MHDnTJ_v84T8BXz5-uF18QpdXF8vF_BK1XPKMhJWkcbwzWGInrXO4wg11dWMbIawVvCZGUKZo1VZWYcddU3edVE5S6TiV7AS83_tOm2aw3W7JaHo9RT-YuNXBeP13Z_RrvQr3WtWspjUpBqcPBjF829iU9eBTa_vejDZskqZSVFJWqq6L9NU_0ruwiWM5b6cqeCqmVFHRvaqNIaVo3WEZgvUOvt7D1wW-_glfizL08s8zDiO_aBcB2wtSaRWU8Xf2f2x_ALcEvLE</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2768915399</pqid></control><display><type>article</type><title>Mortality in psoriatic arthritis patients, changes over time, and the impact of COVID-19: results from a multicenter Psoriatic Arthritis Registry (PsART-ID)</title><source>MEDLINE</source><source>Springer Nature - Complete Springer Journals</source><creator>Erden, Abdulsamet ; Ayan, Gizem ; Kilic, Levent ; Solmaz, Dilek ; Bakirci, Sibel ; Kimyon, Gezmis ; Günal, Esen Kasapoglu ; Dogru, Atalay ; Bayindir, Ozun ; Dalkilic, Ediz ; Özisler, Cem ; Akar, Servet ; Cetin, Gözde Yildirim ; Tarhan, Emine Figen ; Küçüksahin, Orhan ; Omma, Ahmet ; Gonullu, Emel ; Yildiz, Fatih ; Ersozlu, Emine Duygu ; Cinar, Muhammed ; Tufan, Abdurrahman ; Pehlevan, Seval ; Esmen, Serpil Ergulu ; Yilmaz, Sema ; Duruoz, Tuncay ; Kasifoglu, Timucin ; Yazısız, Veli ; Aksu, Kenan ; Aydin, Sibel Zehra ; Kalyoncu, Umut</creator><creatorcontrib>Erden, Abdulsamet ; Ayan, Gizem ; Kilic, Levent ; Solmaz, Dilek ; Bakirci, Sibel ; Kimyon, Gezmis ; Günal, Esen Kasapoglu ; Dogru, Atalay ; Bayindir, Ozun ; Dalkilic, Ediz ; Özisler, Cem ; Akar, Servet ; Cetin, Gözde Yildirim ; Tarhan, Emine Figen ; Küçüksahin, Orhan ; Omma, Ahmet ; Gonullu, Emel ; Yildiz, Fatih ; Ersozlu, Emine Duygu ; Cinar, Muhammed ; Tufan, Abdurrahman ; Pehlevan, Seval ; Esmen, Serpil Ergulu ; Yilmaz, Sema ; Duruoz, Tuncay ; Kasifoglu, Timucin ; Yazısız, Veli ; Aksu, Kenan ; Aydin, Sibel Zehra ; Kalyoncu, Umut</creatorcontrib><description>Background
This study aimed to assess the mortality of PsA before and during the COVID-19 pandemic.
Methods
From the prospective, multicenter PsART-ID (Psoriatic Arthritis Registry-International Database), patients from Turkey were analyzed by linking the registry to the Turkish Cause of Death Registry. The outcome of interest was death from any cause, pre-pandemic (since the onset of registry—March 2014–March 2020), and during the pandemic (March 2020–May 2021). The crude mortality rate and standardized mortality ratio (SMR) were determined.
Results
There were 1216 PsA patients with a follow-up of 7500 patient-years. Overall, 46 deaths (26 males) were observed. In the pre-pandemic period, SMR for PsA vs the general population was 0.95 (0.61–1.49), being higher in males [1.56 (0.92–2.63)] than females [0.62 (0.33–1.17)]. The crude mortality rate in PsA doubled during the pandemic (pre-pandemic crude mortality rate: 5.07 vs 10.76 during the pandemic) with a higher increase in females (2.9 vs 8.72) than males (9.07 vs 14.73).
Conclusion
The mortality in PsA was found similar to the general population in the pre-pandemic era. The mortality rates in PsA doubled during the pandemic. Whether PsA patients have more risk of mortality than the general population due to COVID-19 needs further studies.
Key Points
• Decrease in mortality in PsA might be expected with the more effective treatment options and better disease control.
• A crude mortality rate is comparable to the general population and not increased until the pandemic.
• Currently, there is a 2-fold increase in crude mortality rate possibly due to the COVID-19.</description><identifier>ISSN: 0770-3198</identifier><identifier>EISSN: 1434-9949</identifier><identifier>DOI: 10.1007/s10067-022-06492-6</identifier><identifier>PMID: 36637636</identifier><language>eng</language><publisher>Cham: Springer International Publishing</publisher><subject>Arthritis ; Arthritis, Psoriatic - mortality ; Coronaviruses ; COVID-19 ; COVID-19 - epidemiology ; Disease control ; Female ; Humans ; Male ; Males ; Medicine ; Medicine & Public Health ; Mortality ; Original ; Original Article ; Pandemics ; Prospective Studies ; Psoriatic arthritis ; Registries ; Rheumatology ; Turkey - epidemiology</subject><ispartof>Clinical rheumatology, 2023-02, Vol.42 (2), p.385-390</ispartof><rights>The Author(s), under exclusive licence to International League of Associations for Rheumatology (ILAR) 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.</rights><rights>2023. The Author(s), under exclusive licence to International League of Associations for Rheumatology (ILAR).</rights><rights>The Author(s), under exclusive licence to International League of Associations for Rheumatology (ILAR) 2023, Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c474t-6e71bf4da070f7eff050b2f8beb66ee6481a623925c5e90f4fb8dd79f727f4273</citedby><cites>FETCH-LOGICAL-c474t-6e71bf4da070f7eff050b2f8beb66ee6481a623925c5e90f4fb8dd79f727f4273</cites><orcidid>0000-0001-7129-2109</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s10067-022-06492-6$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s10067-022-06492-6$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>230,314,776,780,881,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36637636$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Erden, Abdulsamet</creatorcontrib><creatorcontrib>Ayan, Gizem</creatorcontrib><creatorcontrib>Kilic, Levent</creatorcontrib><creatorcontrib>Solmaz, Dilek</creatorcontrib><creatorcontrib>Bakirci, Sibel</creatorcontrib><creatorcontrib>Kimyon, Gezmis</creatorcontrib><creatorcontrib>Günal, Esen Kasapoglu</creatorcontrib><creatorcontrib>Dogru, Atalay</creatorcontrib><creatorcontrib>Bayindir, Ozun</creatorcontrib><creatorcontrib>Dalkilic, Ediz</creatorcontrib><creatorcontrib>Özisler, Cem</creatorcontrib><creatorcontrib>Akar, Servet</creatorcontrib><creatorcontrib>Cetin, Gözde Yildirim</creatorcontrib><creatorcontrib>Tarhan, Emine Figen</creatorcontrib><creatorcontrib>Küçüksahin, Orhan</creatorcontrib><creatorcontrib>Omma, Ahmet</creatorcontrib><creatorcontrib>Gonullu, Emel</creatorcontrib><creatorcontrib>Yildiz, Fatih</creatorcontrib><creatorcontrib>Ersozlu, Emine Duygu</creatorcontrib><creatorcontrib>Cinar, Muhammed</creatorcontrib><creatorcontrib>Tufan, Abdurrahman</creatorcontrib><creatorcontrib>Pehlevan, Seval</creatorcontrib><creatorcontrib>Esmen, Serpil Ergulu</creatorcontrib><creatorcontrib>Yilmaz, Sema</creatorcontrib><creatorcontrib>Duruoz, Tuncay</creatorcontrib><creatorcontrib>Kasifoglu, Timucin</creatorcontrib><creatorcontrib>Yazısız, Veli</creatorcontrib><creatorcontrib>Aksu, Kenan</creatorcontrib><creatorcontrib>Aydin, Sibel Zehra</creatorcontrib><creatorcontrib>Kalyoncu, Umut</creatorcontrib><title>Mortality in psoriatic arthritis patients, changes over time, and the impact of COVID-19: results from a multicenter Psoriatic Arthritis Registry (PsART-ID)</title><title>Clinical rheumatology</title><addtitle>Clin Rheumatol</addtitle><addtitle>Clin Rheumatol</addtitle><description>Background
This study aimed to assess the mortality of PsA before and during the COVID-19 pandemic.
Methods
From the prospective, multicenter PsART-ID (Psoriatic Arthritis Registry-International Database), patients from Turkey were analyzed by linking the registry to the Turkish Cause of Death Registry. The outcome of interest was death from any cause, pre-pandemic (since the onset of registry—March 2014–March 2020), and during the pandemic (March 2020–May 2021). The crude mortality rate and standardized mortality ratio (SMR) were determined.
Results
There were 1216 PsA patients with a follow-up of 7500 patient-years. Overall, 46 deaths (26 males) were observed. In the pre-pandemic period, SMR for PsA vs the general population was 0.95 (0.61–1.49), being higher in males [1.56 (0.92–2.63)] than females [0.62 (0.33–1.17)]. The crude mortality rate in PsA doubled during the pandemic (pre-pandemic crude mortality rate: 5.07 vs 10.76 during the pandemic) with a higher increase in females (2.9 vs 8.72) than males (9.07 vs 14.73).
Conclusion
The mortality in PsA was found similar to the general population in the pre-pandemic era. The mortality rates in PsA doubled during the pandemic. Whether PsA patients have more risk of mortality than the general population due to COVID-19 needs further studies.
Key Points
• Decrease in mortality in PsA might be expected with the more effective treatment options and better disease control.
• A crude mortality rate is comparable to the general population and not increased until the pandemic.
• Currently, there is a 2-fold increase in crude mortality rate possibly due to the COVID-19.</description><subject>Arthritis</subject><subject>Arthritis, Psoriatic - mortality</subject><subject>Coronaviruses</subject><subject>COVID-19</subject><subject>COVID-19 - epidemiology</subject><subject>Disease control</subject><subject>Female</subject><subject>Humans</subject><subject>Male</subject><subject>Males</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Mortality</subject><subject>Original</subject><subject>Original Article</subject><subject>Pandemics</subject><subject>Prospective Studies</subject><subject>Psoriatic arthritis</subject><subject>Registries</subject><subject>Rheumatology</subject><subject>Turkey - epidemiology</subject><issn>0770-3198</issn><issn>1434-9949</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNp9kc1uEzEUhS1ERUPhBVggS2yKVIP_xh6zQIpSKJGKWlWFreWZsRNXM-PBdirlXXhYHFLCz4KNrat77jn36gPgBcFvCMbybSqvkAhTirDgiiLxCMwIZxwpxdVjMMNSYsSIqo_B05TuMMa0VuQJOGZCMCmYmIHvn0PMpvd5C_0IpxSiN9m30MS8jj77BKdS2zGnM9iuzbiyCYZ7G2H2gz2DZuxgXlvoh8m0GQYHF1dfl-eIqHcw2rTpc4IuhgEaOJTCt8WpDF8fcuaHnBu78inHLTy9TvObW7Q8f_0MHDnTJ_v84T8BXz5-uF18QpdXF8vF_BK1XPKMhJWkcbwzWGInrXO4wg11dWMbIawVvCZGUKZo1VZWYcddU3edVE5S6TiV7AS83_tOm2aw3W7JaHo9RT-YuNXBeP13Z_RrvQr3WtWspjUpBqcPBjF829iU9eBTa_vejDZskqZSVFJWqq6L9NU_0ruwiWM5b6cqeCqmVFHRvaqNIaVo3WEZgvUOvt7D1wW-_glfizL08s8zDiO_aBcB2wtSaRWU8Xf2f2x_ALcEvLE</recordid><startdate>20230201</startdate><enddate>20230201</enddate><creator>Erden, Abdulsamet</creator><creator>Ayan, Gizem</creator><creator>Kilic, Levent</creator><creator>Solmaz, Dilek</creator><creator>Bakirci, Sibel</creator><creator>Kimyon, Gezmis</creator><creator>Günal, Esen Kasapoglu</creator><creator>Dogru, Atalay</creator><creator>Bayindir, Ozun</creator><creator>Dalkilic, Ediz</creator><creator>Özisler, Cem</creator><creator>Akar, Servet</creator><creator>Cetin, Gözde Yildirim</creator><creator>Tarhan, Emine Figen</creator><creator>Küçüksahin, Orhan</creator><creator>Omma, Ahmet</creator><creator>Gonullu, Emel</creator><creator>Yildiz, Fatih</creator><creator>Ersozlu, Emine Duygu</creator><creator>Cinar, Muhammed</creator><creator>Tufan, Abdurrahman</creator><creator>Pehlevan, Seval</creator><creator>Esmen, Serpil Ergulu</creator><creator>Yilmaz, Sema</creator><creator>Duruoz, Tuncay</creator><creator>Kasifoglu, Timucin</creator><creator>Yazısız, Veli</creator><creator>Aksu, Kenan</creator><creator>Aydin, Sibel Zehra</creator><creator>Kalyoncu, Umut</creator><general>Springer International Publishing</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7T5</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PHGZM</scope><scope>PHGZT</scope><scope>PJZUB</scope><scope>PKEHL</scope><scope>PPXIY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-7129-2109</orcidid></search><sort><creationdate>20230201</creationdate><title>Mortality in psoriatic arthritis patients, changes over time, and the impact of COVID-19: results from a multicenter Psoriatic Arthritis Registry (PsART-ID)</title><author>Erden, Abdulsamet ; Ayan, Gizem ; Kilic, Levent ; Solmaz, Dilek ; Bakirci, Sibel ; Kimyon, Gezmis ; Günal, Esen Kasapoglu ; Dogru, Atalay ; Bayindir, Ozun ; Dalkilic, Ediz ; Özisler, Cem ; Akar, Servet ; Cetin, Gözde Yildirim ; Tarhan, Emine Figen ; Küçüksahin, Orhan ; Omma, Ahmet ; Gonullu, Emel ; Yildiz, Fatih ; Ersozlu, Emine Duygu ; Cinar, Muhammed ; Tufan, Abdurrahman ; Pehlevan, Seval ; Esmen, Serpil Ergulu ; Yilmaz, Sema ; Duruoz, Tuncay ; Kasifoglu, Timucin ; Yazısız, Veli ; Aksu, Kenan ; Aydin, Sibel Zehra ; Kalyoncu, Umut</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c474t-6e71bf4da070f7eff050b2f8beb66ee6481a623925c5e90f4fb8dd79f727f4273</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Arthritis</topic><topic>Arthritis, Psoriatic - mortality</topic><topic>Coronaviruses</topic><topic>COVID-19</topic><topic>COVID-19 - epidemiology</topic><topic>Disease control</topic><topic>Female</topic><topic>Humans</topic><topic>Male</topic><topic>Males</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Mortality</topic><topic>Original</topic><topic>Original Article</topic><topic>Pandemics</topic><topic>Prospective Studies</topic><topic>Psoriatic arthritis</topic><topic>Registries</topic><topic>Rheumatology</topic><topic>Turkey - epidemiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Erden, Abdulsamet</creatorcontrib><creatorcontrib>Ayan, Gizem</creatorcontrib><creatorcontrib>Kilic, Levent</creatorcontrib><creatorcontrib>Solmaz, Dilek</creatorcontrib><creatorcontrib>Bakirci, Sibel</creatorcontrib><creatorcontrib>Kimyon, Gezmis</creatorcontrib><creatorcontrib>Günal, Esen Kasapoglu</creatorcontrib><creatorcontrib>Dogru, Atalay</creatorcontrib><creatorcontrib>Bayindir, Ozun</creatorcontrib><creatorcontrib>Dalkilic, Ediz</creatorcontrib><creatorcontrib>Özisler, Cem</creatorcontrib><creatorcontrib>Akar, Servet</creatorcontrib><creatorcontrib>Cetin, Gözde Yildirim</creatorcontrib><creatorcontrib>Tarhan, Emine Figen</creatorcontrib><creatorcontrib>Küçüksahin, Orhan</creatorcontrib><creatorcontrib>Omma, Ahmet</creatorcontrib><creatorcontrib>Gonullu, Emel</creatorcontrib><creatorcontrib>Yildiz, Fatih</creatorcontrib><creatorcontrib>Ersozlu, Emine Duygu</creatorcontrib><creatorcontrib>Cinar, Muhammed</creatorcontrib><creatorcontrib>Tufan, Abdurrahman</creatorcontrib><creatorcontrib>Pehlevan, Seval</creatorcontrib><creatorcontrib>Esmen, Serpil Ergulu</creatorcontrib><creatorcontrib>Yilmaz, Sema</creatorcontrib><creatorcontrib>Duruoz, Tuncay</creatorcontrib><creatorcontrib>Kasifoglu, Timucin</creatorcontrib><creatorcontrib>Yazısız, Veli</creatorcontrib><creatorcontrib>Aksu, Kenan</creatorcontrib><creatorcontrib>Aydin, Sibel Zehra</creatorcontrib><creatorcontrib>Kalyoncu, Umut</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Immunology Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest Central (New)</collection><collection>ProQuest One Academic (New)</collection><collection>ProQuest Health & Medical Research Collection</collection><collection>ProQuest One Academic Middle East (New)</collection><collection>ProQuest One Health & Nursing</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Clinical rheumatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Erden, Abdulsamet</au><au>Ayan, Gizem</au><au>Kilic, Levent</au><au>Solmaz, Dilek</au><au>Bakirci, Sibel</au><au>Kimyon, Gezmis</au><au>Günal, Esen Kasapoglu</au><au>Dogru, Atalay</au><au>Bayindir, Ozun</au><au>Dalkilic, Ediz</au><au>Özisler, Cem</au><au>Akar, Servet</au><au>Cetin, Gözde Yildirim</au><au>Tarhan, Emine Figen</au><au>Küçüksahin, Orhan</au><au>Omma, Ahmet</au><au>Gonullu, Emel</au><au>Yildiz, Fatih</au><au>Ersozlu, Emine Duygu</au><au>Cinar, Muhammed</au><au>Tufan, Abdurrahman</au><au>Pehlevan, Seval</au><au>Esmen, Serpil Ergulu</au><au>Yilmaz, Sema</au><au>Duruoz, Tuncay</au><au>Kasifoglu, Timucin</au><au>Yazısız, Veli</au><au>Aksu, Kenan</au><au>Aydin, Sibel Zehra</au><au>Kalyoncu, Umut</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Mortality in psoriatic arthritis patients, changes over time, and the impact of COVID-19: results from a multicenter Psoriatic Arthritis Registry (PsART-ID)</atitle><jtitle>Clinical rheumatology</jtitle><stitle>Clin Rheumatol</stitle><addtitle>Clin Rheumatol</addtitle><date>2023-02-01</date><risdate>2023</risdate><volume>42</volume><issue>2</issue><spage>385</spage><epage>390</epage><pages>385-390</pages><issn>0770-3198</issn><eissn>1434-9949</eissn><abstract>Background
This study aimed to assess the mortality of PsA before and during the COVID-19 pandemic.
Methods
From the prospective, multicenter PsART-ID (Psoriatic Arthritis Registry-International Database), patients from Turkey were analyzed by linking the registry to the Turkish Cause of Death Registry. The outcome of interest was death from any cause, pre-pandemic (since the onset of registry—March 2014–March 2020), and during the pandemic (March 2020–May 2021). The crude mortality rate and standardized mortality ratio (SMR) were determined.
Results
There were 1216 PsA patients with a follow-up of 7500 patient-years. Overall, 46 deaths (26 males) were observed. In the pre-pandemic period, SMR for PsA vs the general population was 0.95 (0.61–1.49), being higher in males [1.56 (0.92–2.63)] than females [0.62 (0.33–1.17)]. The crude mortality rate in PsA doubled during the pandemic (pre-pandemic crude mortality rate: 5.07 vs 10.76 during the pandemic) with a higher increase in females (2.9 vs 8.72) than males (9.07 vs 14.73).
Conclusion
The mortality in PsA was found similar to the general population in the pre-pandemic era. The mortality rates in PsA doubled during the pandemic. Whether PsA patients have more risk of mortality than the general population due to COVID-19 needs further studies.
Key Points
• Decrease in mortality in PsA might be expected with the more effective treatment options and better disease control.
• A crude mortality rate is comparable to the general population and not increased until the pandemic.
• Currently, there is a 2-fold increase in crude mortality rate possibly due to the COVID-19.</abstract><cop>Cham</cop><pub>Springer International Publishing</pub><pmid>36637636</pmid><doi>10.1007/s10067-022-06492-6</doi><tpages>6</tpages><orcidid>https://orcid.org/0000-0001-7129-2109</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0770-3198 |
| ispartof | Clinical rheumatology, 2023-02, Vol.42 (2), p.385-390 |
| issn | 0770-3198 1434-9949 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9838281 |
| source | MEDLINE; Springer Nature - Complete Springer Journals |
| subjects | Arthritis Arthritis, Psoriatic - mortality Coronaviruses COVID-19 COVID-19 - epidemiology Disease control Female Humans Male Males Medicine Medicine & Public Health Mortality Original Original Article Pandemics Prospective Studies Psoriatic arthritis Registries Rheumatology Turkey - epidemiology |
| title | Mortality in psoriatic arthritis patients, changes over time, and the impact of COVID-19: results from a multicenter Psoriatic Arthritis Registry (PsART-ID) |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-18T21%3A57%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Mortality%20in%20psoriatic%20arthritis%20patients,%20changes%20over%20time,%20and%20the%20impact%20of%20COVID-19:%20results%20from%20a%20multicenter%20Psoriatic%20Arthritis%20Registry%20(PsART-ID)&rft.jtitle=Clinical%20rheumatology&rft.au=Erden,%20Abdulsamet&rft.date=2023-02-01&rft.volume=42&rft.issue=2&rft.spage=385&rft.epage=390&rft.pages=385-390&rft.issn=0770-3198&rft.eissn=1434-9949&rft_id=info:doi/10.1007/s10067-022-06492-6&rft_dat=%3Cproquest_pubme%3E2765775988%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2768915399&rft_id=info:pmid/36637636&rfr_iscdi=true |